Literature DB >> 8238142

Reproducibility of the oral glucose tolerance test in pregnant women.

P M Catalano1, D A Avallone, N M Drago, S B Amini.   

Abstract

OBJECTIVE: The purpose of this study was to evaluate the reproducibility of the 3-hour oral glucose tolerance test during pregnancy and the potential factors associated with nonreproducible results. STUDY
DESIGN: Thirty-eight women with a 1-hour glucose level > or 135 mg/dl had a 100 gm oral glucose tolerance test. During the test samples were obtained for glucose, insulin, cortisol, human placental lactogen, and norepinephrine levels. The oral glucose tolerance test was repeated 1 week later under similar metabolic conditions.
RESULTS: The intraassay coefficient of variation in glucose from week 1 to week 2 was < 2%. There were no significant differences in the paired fasting 1-, 2-, or 3-hour glucose concentrations (p = 0.51 to 0.96) or the area under the glucose curve (p = 0.43) from week 1 to week 2, although the mean absolute difference in glucose values ranged from 4 (fasting) to 18 (3 hours) mg/dl. Oral glucose tolerance test results were classified as either normal or abnormal from week 1 to week 2; 16 normal/normal, 13 abnormal/abnormal, seven abnormal/normal, and two normal/abnormal. Norepinephrine (p = 0.03) and insulin (p = 0.05) were significantly greater in week 1 but not in week 2 in the abnormal/normal versus normal/normal and abnormal/abnormal groups. There were no significant differences in cortisol or human placental lactogen levels among groups at any time.
CONCLUSIONS: The oral glucose tolerance test was not reproducible for diagnosis in 24% (nine of 38) of pregnant women. We speculate that maternal stress (increased norepinephrine) may have been a factor for the abnormal results in week 1 in the abnormal/normal group.

Entities:  

Mesh:

Substances:

Year:  1993        PMID: 8238142     DOI: 10.1016/0002-9378(93)90019-f

Source DB:  PubMed          Journal:  Am J Obstet Gynecol        ISSN: 0002-9378            Impact factor:   8.661


  16 in total

Review 1.  Establishing consensus in the diagnosis of gestational diabetes following HAPO: where do we stand?

Authors:  Hélène Long; Tim Cundy
Journal:  Curr Diab Rep       Date:  2013-02       Impact factor: 4.810

2.  Plasma Glycated CD59 Predicts Early Gestational Diabetes and Large for Gestational Age Newborns.

Authors:  DongDong Ma; Miguel Angel Luque-Fernandez; Delia Bogdanet; Gernot Desoye; Fidelma Dunne; Jose A Halperin
Journal:  J Clin Endocrinol Metab       Date:  2020-04-01       Impact factor: 5.958

Review 3.  The utility of a single test to identify women at risk for gestational diabetes.

Authors:  D A Sacks
Journal:  Curr Diab Rep       Date:  2001-08       Impact factor: 4.810

4.  Paired values of serum fructosamine and blood glucose for the screening of gestational diabetes mellitus: A retrospective study of 165 Saudi pregnant women.

Authors:  Haseeb Ahmad Khan; Samia Hasan Sobki; Abdullah Saleh Alhomida; Shaukat Ali Khan
Journal:  Indian J Clin Biochem       Date:  2007-03

5.  Diagnosing gestational diabetes.

Authors:  E A Ryan
Journal:  Diabetologia       Date:  2011-01-04       Impact factor: 10.122

6.  Gestational diabetes mellitus: A window of opportunity.

Authors:  Sanjay Kalra; Sonia Malik; Mathew John
Journal:  Indian J Endocrinol Metab       Date:  2011-07

Review 7.  Updated guidelines on screening for gestational diabetes.

Authors:  Yashdeep Gupta; Bharti Kalra; Manash P Baruah; Rajiv Singla; Sanjay Kalra
Journal:  Int J Womens Health       Date:  2015-05-19

8.  Reproducibility of the 75 g oral glucose tolerance test for the diagnosis of gestational diabetes mellitus in a sub-Saharan African population.

Authors:  Yvonne Nangeh Munang; Jean Jacques Noubiap; Celestin Danwang; Julius Dohbit Sama; Marcel Azabji-Kenfack; Jean Claude Mbanya; Eugene Sobngwi
Journal:  BMC Res Notes       Date:  2017-11-28

9.  HbA1c as screening for gestational diabetes mellitus in women with polycystic ovary syndrome.

Authors:  Ingrid Hov Odsæter; Arne Åsberg; Eszter Vanky; Sven Magnus Carlsen
Journal:  BMC Endocr Disord       Date:  2015-08-06       Impact factor: 2.763

10.  Hemoglobin A1c as screening for gestational diabetes mellitus in Nordic Caucasian women.

Authors:  Ingrid Hov Odsæter; Arne Åsberg; Eszter Vanky; Siv Mørkved; Signe Nilssen Stafne; Kjell Åsmund Salvesen; Sven Magnus Carlsen
Journal:  Diabetol Metab Syndr       Date:  2016-07-22       Impact factor: 3.320

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.